|
Doak, The popularity of this thread depends on
what I call the fast driving
syndrome. If the market is
sitting still, nobody posts much. But if we are
driving fast, then we are either the windshield or the bug, and both
can be interesting. -G- Genzyme Tissue Repair is symbol GENZL. They
are a subsidiary of Genzyme Corp, as is another favorite of mine,
Genzyme Transgenics (GZTC). GENZL has a product called Cericel which
they implant into knee tissue to repair damages. It is being sold,
but it is not without controversy, which is why the stock is down from
the thirties. The main thing I like about Genzl is that their entire
pipeline is filled with interesting products, many of which I beleive
will be better than Cericel. Having a parent with deep pockets is
also quite handy.
Sang-Stat, symbol SANG, is primarily in the immune system area
and their lead product is a generic form of cyclosporine, for organ
transplant patients. My mother had a liver and kidney transplant and
she takes Cyclosporine and it is one expensive drug. $750-1100 a
month and she is on a low dose. The generic, when it is released,
will be very popular. They have a deep pipeline and some big doper
support. Good luck, MB |
